Labiotech.eu

News and Trends 25 Jul 2018

Two Drugs as Good as Three for Treating HIV

ViiV Healthcare reports promising data from two HIV treatments with two drugs instead of the usual three, which have the potential to reduce the side effects of antiretroviral therapy in the long term. People infected with HIV are treated with lifelong antiretroviral therapy, which traditionally consists of three or more different drugs. The British […]

July 25, 2018 - 3 minutesmins - By Clara Rodríguez Fernández

News and Trends 25 Jul 2018

Austrian Researchers Grow Cancerous Mini Brains in a Dish

Researchers in Vienna are growing mini brains that mimic the onset and development of brain cancer, which could be used to compare the efficacy of different treatments. Because of their cellular complexity, brain cancers have been difficult to study in animals. Glioblastoma, the most aggressive form of brain cancer, is particularly difficult to treat because […]

July 25, 2018 - 2 minutesmins - By Alexander Burik

News and Trends 24 Jul 2018

Celyad’s Donor Cell CAR-T Therapy Gets Closer to the Clinic

Celyad has received FDA approval to start clinical trials for its CAR-T cell therapy, which is engineered to avoid side effects associated with using donor cells for this kind of treatment. The Belgian biotech has been cleared to test its CAR-T cell therapy, made from donor cells, in patients with unresectable colorectal cancer in combination […]

July 24, 2018 - 2 minutesmins - By Alexander Burik

Interview 24 Jul 2018

Meet the Dutch Scientists who Invented Keytruda, “The President’s Drug”

Known for curing US President Jimmy Carter’s cancer, Keytruda continues to benefit many other cancer patients. The inventors told us their story, from the drug’s early days to their current role as executives of the biotech unicorn Aduro. Since 2014, the cancer drug Keytruda, also known as pembrolizumab, continues to be widely sought after due […]

July 24, 2018 - 6 minutesmins - By Editorial Team

News and Trends 23 Jul 2018

UK Biotech to Launch Rapid, Accurate HIV Test in Europe

UK-biotech Owen Mumford plans to launch an HIV diagnostic test in Europe that can produce an accurate result within 15 minutes. Current rapid diagnostic tests for HIV can lead to misdiagnosis, for example when steps in the procedure are not followed in the right order, or too little blood is drawn. The new test, called […]

July 23, 2018 - 2 minutesmins - By Alexander Burik

News and Trends 23 Jul 2018

Sangamo Acquires French Biotech to Develop CAR-T Therapies for Autoimmune Disease

Sangamo Therapeutics has acquired TxCell with a view to utilizing its CAR-T technology to prevent organ transplant rejections and treat autoimmune disease. Sangamo, based in California, is known for bringing the first in-vivo gene therapy to the market. The company entered into an agreement to purchase TxCell for €72M. Sangamo plans to combine its zinc […]

July 23, 2018 - 3 minutesmins - By Alexander Burik

Somewhere in Between Wellcome Collection 1

News and Trends 21 Jul 2018

Somewhere in Between: Exploring Art and Science Collaborations

The latest art and science exhibition at the Wellcome Collection, Somewhere in Between, explores ideas about cattle farming, multisensory synaesthesia, sexual health and virus transmission, and the human capacity to breathe. In an unprecedented level of collaboration, the exhibition is comprised of four art-science projects stemming from projects funded by the Wellcome Trust with the […]

July 21, 2018 - 4 minutesmins - By External Contributor

News and Trends 20 Jul 2018

Belgian Biotech Completes First Trial with New Drug for Diabetic Macular Edema

Belgian biotech ThromboGenics has conducted the first clinical trial of an antibody to treat one of the world’s leading causes of vision loss. Results from the Phase I/II trial demonstrate the safety and tolerability of a new kind of antibody treatment for diabetic macular edema. The trial focused on injecting the THR-317 antibody, which is directed against […]

July 20, 2018 - 2 minutesmins - By External Contributor

News and Trends 20 Jul 2018

German Private Equity Firm Raises €90M for Life Sciences and Medtech

SHS has raised €90M in the first closing of its fifth fund dedicated to companies in life sciences and medtech. SHS, based in Tübingen, is aiming to raise a total of €150M for its fifth fund. In this first closing, around half of the €90M raised came from existing investors including professional pension insurers and family […]

July 20, 2018 - 1 minutemin - By Alexander Burik

News and Trends 19 Jul 2018

Kite Partners with Dutch Biotech to Develop a New Form of CAR-T Therapy

Kite will support Gadeta in the development of a new type of CAR-T therapy that could be more effective in solid tumors. Approved just last year, CAR-T cell therapy is offering hope to patients with severe forms of blood cancer. The developer of one of only two CAR-T therapies currently in the market, Kite, has […]

July 19, 2018 - 3 minutesmins - By Clara Rodríguez Fernández

More News! 18 Jul 2018

Lab-Grown Meat Will Be on the Market in 2021

Dutch startup Mosa Meat has raised €7.5M in a Series A round, which will support the development of a first lab-grown meat product that is expected to make it to market by 2021. Mosa Meat is a Dutch startup co-founded by Mark Post, the scientist behind the world’s first lab-grown burger. After an early investment […]

July 18, 2018 - 3 minutesmins - By Clara Rodríguez Fernández

News and Trends 17 Jul 2018

Gene Therapy Could Prevent Deadly Brain Disease

An international research team used gene therapy to prevent Gaucher disease, a potentially deadly neurodegenerative condition, in mice. The approach could eventually be used to treat human diseases in the womb. A research team from the UK and Singapore showed that a neurodegenerative condition called Gaucher disease, which can be fatal, can be prevented in […]

July 17, 2018 - 3 minutesmins - By Alexander Burik

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Two Drugs as Good as Three for Treating HIV

Austrian Researchers Grow Cancerous Mini Brains in a Dish

Celyad’s Donor Cell CAR-T Therapy Gets Closer to the Clinic

Meet the Dutch Scientists who Invented Keytruda, “The President’s Drug”

UK Biotech to Launch Rapid, Accurate HIV Test in Europe

Sangamo Acquires French Biotech to Develop CAR-T Therapies for Autoimmune Disease

Somewhere in Between: Exploring Art and Science Collaborations

Belgian Biotech Completes First Trial with New Drug for Diabetic Macular Edema

German Private Equity Firm Raises €90M for Life Sciences and Medtech

Kite Partners with Dutch Biotech to Develop a New Form of CAR-T Therapy

Lab-Grown Meat Will Be on the Market in 2021

Gene Therapy Could Prevent Deadly Brain Disease

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!